Application of general practice team management in patients with mild to moderate Alzheimer′s disease
ZHANG Yuan-ya1 ZHENG Wen1 LIAO Ling1 YANG Shui-feng1 WU Cheng-hui1 TAO Ming-hua2 HUANG Chen1
1. Department of General Medicine, Shangrao People′s Hospital, Jiangxi Province, Shangrao 334000, China;
2. Community Health Service Center, Beimen Street, Xinzhou District, Jiangxi Province, Shangrao 334000, China
Abstract：Objective To explore the effect of general practice team management in patients with mild to moderate Alzheimer′s disease (AD). Methods A total of 96 patients with mild to moderate AD who were followed up by Shangrao People′s Hospital and Beimen Street Community Health Service Center, Xinzhou District, Shangrao City from January 2016 to December 2019 were selected as the research objects, and were divided into experimental group and the control group according to the random number table method, each with 48 cases. The experimental group was managed by a general practice team, and the control group was managed by routine self-management. Analyze the dopezil hydrochloride and memantine hydrochloride medication rates, mini-mental state examination (MMSE) scores, activities of daily living (ADL) scores, hospital admission rates, and family caregivers′ Zarit burden questionnaire (ZBI) between the two groups of patients score. Results After 1 year of follow-up, the rate of medication in the experimental group was higher than that of the control group, and the difference was statistically significant (P<0.05). After intervention, the MMSE score and ADL score of the experimental group were higher than those of the control group, and the hospital admission rate and ZBI score were lower than the control group, the differences were statistically significant (P＜0.05).Conclusion General practice team management for patients with mild to moderate AD can improve treatment compliance, better disease control, and reduce the burden on family caregivers with better results.
张元亚;郑文;廖玲; 杨水凤;吴成辉;陶明华;黄晨. 全科团队式管理在轻中度阿尔茨海默病患者中的应用[J]. 中国当代医药, 2021, 28(34): 69-72.
ZHANG Yuan-ya; ZHENG Wen;LIAO Ling;YANG Shui-feng;WU Cheng-hui;TAO Ming-hua;HUANG Chen. Application of general practice team management in patients with mild to moderate Alzheimer′s disease. 中国当代医药, 2021, 28(34): 69-72.
Thyrian JR，Hertel J，Wucherer D，et al.Effectiveness and Safety of Dementia Care Management in Primary Care：A Randomized Clinical Trial[J].JAMA Psychiatry，2017，74（10）：996-1004.
[5]
Reisberg B，Shao Y，Golomb J，et al.Comprehensive，Individualized，Person-Centered Management of Community-Residing Persons with Moderate-to-Severe Alzheimer Disease：A Randomized Controlled Trial[J].Dement Geriatr Cogn Disord，2017，43（1-2）：100-117.
Wade DT，Collin C.The Barthel ADL Index：a standard measure of physical disability?[J].Int Disabil Stud，1988，10（2）：64-67.
[10]
Sperling RA，Aisen PS，Beckett LA，et al.Toward defining the preclinical stages of Alzheimer′s disease：recommendations from the National Institute on Aging-Alzheimer′s Association workgroups on diagnostic guidelines for Alzheimer′s disease[J].Alzheimers Dement，2011，7（3）：280-292.
[11]
Li H，Jia J，Yang Z.Mini -Mental State Examination in Elderly Chinese：A Population-Based Normative Study[J].J Alzheimers Dis，2016，53（2）：487-496.
[14]
Teri L，Logsdon RG，Mccurry SM，et al.Translating an Evidence-based Multicomponent Intervention for Older Adults With Dementia and Caregivers[J].Gerontologist，2020，60（3）：548-557.
[15]
Briggs R，Kennelly SP，O′ Neill D.Drug treatments in Alzheimer′s disease[J].Clin Med（Lond），2016，16（3）：247-253.
[16]
Chen Z，Yang X，Song Y，et al.Challenges of Dementia Care in China[J].Geriatrics（Basel），2017，2（1）：7.
[17]
Ashford J W.Treatment of Alzheimer′s Disease：Trazodone，Sleep，Serotonin，Norepinephrine，and Future Directions[J].J Alzheimers Dis，2019，67（3）：923-930.
[18]
Quail Z，Carter MM，Wei A，et al.Management of cognitive decline in Alzheimer′s disease using a non-pharmacological intervention program：A case report[J].Medicine （Baltimore），2020，99（21）：e20128.
[19]
Reuben DB，Tan ZS，Romero T，et al.Patient and Caregiver Benefit From a Comprehensive Dementia Care Program：1-Year Results From the UCLA Alzheimer′s and Dementia Care Program[J].J Am Geriatr Soc，2019，67（11）：2267-2273.
京公网安备 11010502046607号